STEVENSON, Md., Feb. 27, 2018 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Ekso Bionics Holdings, Inc. (Nasdaq:EKSO) (“Ekso” or the “Company”) securities during the period between March 15, 2017 and December 27, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 5, 2018 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Ekso securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that there was a material weakness in Ekso’s internal control over financial reporting.
According to the complaint, following a December 14, 2017 U.S. Securities and Exchange Commission filing stating that the Company’s internal controls were not effective, and a December 27, 2017 filing of its amended annual and quarterly reports, the value of Ekso shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Ekso securities purchased on or after March 15, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]


Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
OpenAI Restricts Astra AI Over Cyberattack Risks
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 



